Inify Laboratories AB (WY60)
Market Open
10 Aug, 20:00
XFRA XFRA Primary 
XOSL €
0. 44
-0.14
-24.1379%
€
20.04M Market Cap
- P/E Ratio
- Div Yield
0 Volume
0 Eps
€ 0.58
Previous Close Want to track WY60 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Inify Laboratories AB (WY60) Statistics
Valuation metrics
Market Cap 20.04M
Enterprise value -
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.91
Price/Book (mrq) 0.18
Enterprise Value/Revenue -
Enterprise Value/EBITDA -
Overview
Shares outstanding 80.16M
Float -
Shares short -
% Held by insiders 0.67%
% Held by institutions 0.01%
Average volume (10 days) 280
Average volume (90 days) 140
Price summary
52-Week low 0.14
52-Week high 0.8
Beta -
50-Day moving average 0.27
200-Day moving average 0.34
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.85%
Operating margin -3.08%
Operational effectiveness
Return on assets -0.48%
Return on equity -0.63%
Income Statement
Revenue (ttm) 22.01M
Revenue per share (ttm) -
Quarterly revenue growth (yoy) 0.27%
Gross profit (ttm) 18.6M
EBITDA -
Net income to common (ttm) -67.89M
Diluted EPS (ttm) -0.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 57.53M
Total cash per share (mrq) 0.73
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 2.26%
Book value per share (mrq) 1.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -67.89M
